Sign In
Buy ACST
$3.37
+0 (+0%)
At Close: Jan 24, 2025
ACST Stock: Over 10% Increase Pre-Market Explanation
07:35am, Friday, 07'th May 2021
The stock price of Acasti Pharma Inc (NASDAQ: ACST) increased by over 10% pre-market. This is why it happened.
Acasti Announces Definitive Agreement to Acquire Grace Therapeutics, Inc.
07:00am, Friday, 07'th May 2021
Grace provides Acasti with a pipeline of rare and orphan disease programs, including 3 clinical stage assets that have received Orphan Drug Designation from the FDA
Best Penny Stocks to Buy Under $2? Check These 3 Out
03:59pm, Monday, 26'th Apr 2021
Are penny stocks under $2 worth it? Take a look at these 3 to decide The post Best Penny Stocks to Buy Under $2?
Acasti Pharma Stock Is Only Ideal for a Short-Term Trade
08:31am, Wednesday, 17'th Mar 2021
From time to time, ACST stock tends to have massive price spikes. It's too volatile for a long-term position, but may be a trader's paradise.
Acasti Pharma Provides Update on Recent Financing Activities
05:30pm, Monday, 08'th Mar 2021
LAVAL, Quebec, March 08, 2021 (GLOBE NEWSWIRE) -- As required pursuant to the policies of the TSX Venture Exchange, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) i
Acasti Pharma awaiting business review outcome after CaPre drug trial disappointment
12:41pm, Tuesday, 23'rd Feb 2021
TRILOGY 2 study on CaPre did not meet its primary endpoint CaPre was a krill-oil derived prescription drug designed to treat hypertriglyceridemia What Acasti Pharma does: Acasti Pharma Inc (NASDAQ:AC
ACST Stock Price Increases Over 30% Pre-Market: Why It Happened
06:08am, Wednesday, 10'th Feb 2021
The stock price of Acasti Pharma Inc (NASDAQ: ACST – TSX-V: ACST) is trading at over 30% pre-market as of 6:02 AM ET. This is why it happened.
Why Corcept Therapeutics, Acasti Pharma And More Are Moving Today
12:02pm, Tuesday, 09'th Feb 2021
Corcept Therapeutics (NASDAQ: CORT) shares were trading lower Tuesday after the company reported preliminary fourth-quarter sales results and issued fiscal year 2021 sales guidance. Corcept Therapeuti
Acasti Pharma posts fiscal third quarter results as strategic review continues
08:22am, Tuesday, 09'th Feb 2021
Acasti Pharma Inc (NASDAQ:ACST) (CVE:ACST) (FRA:A1PA), which is currently going through a review process aimed at enhancing shareholder value, posted Tuesday its fiscal third-quarter results to end-De
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
06:55am, Tuesday, 09'th Feb 2021
LAVAL, Quebec, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) today announced its operating and financial results for the third qu
ACST Stock Price Increases Over 12% Pre-Market: Why It Happened
06:45am, Thursday, 28'th Jan 2021
The stock price of Acasti Pharma Inc (NASDAQ: ACST) is trading at over 12% pre-market. This is why it happened.
Acasti Pharma Provides Update on Recent Financing Activities
06:55am, Wednesday, 27'th Jan 2021
LAVAL, Québec, Jan. 27, 2021 (GLOBE NEWSWIRE) -- As required pursuant to the policies of the TSX Venture Exchange, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) i
ACST Stock Alert: 13 Things for Acasti Pharma Investors to Know as Shares Rocket Monday
11:19am, Monday, 11'th Jan 2021
Acasti Pharma (ACST) stock is on the rise Monday with heavy trading of its shares despite a lack of news concerning the company. The post ACST Stock Alert: 13 Things for Acasti Pharma Investors to Kno
Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade
12:47pm, Friday, 25'th Dec 2020
Acasti (ACST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Acasti Pharma Unaware of Any Material Change
03:24pm, Wednesday, 23'rd Dec 2020
LAVAL, Québec, Dec. 23, 2020 (GLOBE NEWSWIRE) -- At the request of IIROC, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) wishes to confirm that the Company's manag
